Mr. Lynn D. Torbeck - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Mr. Lynn D. Torbeck


Mr. Lynn D. Torbeck is a Pharmtech editorial advisory board (EAB) member

Mr. Lynn D. Torbeck
Principal Statistician
Torbeck & Associates

Lynn D. Torbeck is a consultant specializing in applied statistics and experimental design for pharmaceutical and biopharmaceutical development, quality assurance and control, validation, and production under the CGMPs. Areas of expertise include quality by design, design space, OOS, SQC/SPC, statistical PAT, assay validation, sampling plans, and setting specification criteria. Torbeck has been active in the pharmaceutical industry in statistics, quality, and management since 1975; he has been president of Torbeck and Assoc., Inc. since 1988. He has worked with a wide variety of companies, including pharmaceuticals, biotechnology, fine chemicals, medical devices, and cosmetics. Torbeck is the author of several books on validation and has published a number of journal articles.

Torbeck has been a member of the Editorial Advisory Board of Pharmaceutical Technology since 1999, and was elected to the PDA Scientific Advisory Board (SAB) in 2002 and the USP Statistics Expert Committee for a second five-year term in 2005. He was chair of the PDA’s SAB Out-Of-Specification committee. He won the PDA TRI Excellence in Teaching Award in 1997 and again in 2007. He is also a member of the ASTM E-11, statistics, and E-55, PAT, committees.

Torbeck is a member of the American Statistical Association, PDA, Senior Member of the American Society for Quality, ASQ, ASTM, and is past president of the Chicago Chapter of the American Statistical Association. He is a past Book Reviews Editor for the Journal of Quality Technology, a publication of the American Society for Quality. He holds an AAS degree in Electronics and BS and MS degrees in Statistics with minors in Operations Research and Computer Science.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
13%
To select process for new products only
26%
To select processes for both new and legacy products
21%
Do not use QbD
21%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search

Click here